NAYA Biosciences, Inc.
NAYANASDAQHealthcare
$2.20
+$0.17(+8.37%)
Market Cap$1465323
P/E Ratio—
52W High$17.04
52W Low$1.38
NAYA Biosciences, Inc. (NAYA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · NAYA · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.53M | $3.02M | $0.82M | $4.16M | $1.04M |
| Cost of Revenue | $3.66M | $1.93M | $0.85M | $0.15M | $0.09M |
| Gross Profit | $2.87M | $1.09M | ($0.03M) | $4.02M | $0.95M |
| Gross Margin %(computed) | 44.00% | 35.96% | -3.48% | 96.51% | 91.44% |
| Operating Expenses | |||||
| R&D Expenses | $0.49M | $0.17M | $0.54M | $0.22M | $0.40M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $11.00M | $7.65M | $10.60M | $9.23M | $6.46M |
| Operating Income | ($8.13M) | ($6.77M) | ($10.63M) | ($5.22M) | ($5.51M) |
| Operating Margin %(computed) | -124.40% | -224.04% | — | -125.39% | -531.67% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $1.06M | $0.93M | $0.06M | $1.27M | $2.84M |
| Income Before Tax | ($9.12M) | ($8.01M) | ($10.89M) | ($6.65M) | ($8.35M) |
| Income Tax Expense | ($0.02M) | $0.03M | $0.00M | $0.00M | $0.00M |
| Net Income | ($9.10M) | ($8.03M) | ($10.89M) | ($6.65M) | ($8.35M) |
| Net Margin %(computed) | -139.25% | -266.00% | — | -159.97% | -804.73% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-30.19 | $-5.13 | $-8.99 | $-6.26 | $-15.21 |
| Wtd Avg Shares | 0.31M | 3.13M | 2.42M | 2.13M | 1.10M |
| EBITDA | ($7.14M) | ($6.88M) | ($10.75M) | ($5.22M) | ($5.48M) |
| EBITDA Margin %(computed) | -109.35% | -227.77% | — | -125.45% | -527.94% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more NAYA Biosciences, Inc. data
About NAYA Biosciences, Inc. (NAYA) Income Statement
NAYA Biosciences, Inc. (NAYA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, NAYA reported revenue of $0.01B, gross profit of $0.00B (gross margin 44.00%), and net income of ($0.01B) — a net profit margin of -139.25%.
Frequently asked questions
NAYA · 4 questionsNAYA Biosciences, Inc. (NAYA) reported revenue of $0.01B for 2024, up 116.3% year-over-year.
NAYA revenueNAYA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09